Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project

Barbara Mora; Toni Giorgino; Paola Guglielmelli; Elisa Rumi; Margherita Maffioli; Alessandro Rambaldi; Marianna Caramella; Rami Komrokji; Jason Gotlib; Jean Jacques Kiladjian; Francisco Cervantes; Timothy Devos; Francesca Palandri; Valerio De Stefano; Marco Ruggeri; Richard T Silver; Giulia Benevolo; Francesco Albano; Chiara Cavalloni; Daniela Barraco; Michele Merli; Daniela Pietra; Rosario Casalone; Tiziano Barbui; Giada Rotunno; Mario Cazzola; Alessandro Maria Vannucchi; Francesco Passamonti

doi:10.3324/haematol.2017.185751

Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project

Haematologica. 2018 Sep;103(9):e392-e394. doi: 10.3324/haematol.2017.185751. Epub 2018 Apr 5.

Authors

Barbara Mora¹, Toni Giorgino², Paola Guglielmelli³, Elisa Rumi⁴, Margherita Maffioli¹, Alessandro Rambaldi⁵, Marianna Caramella⁶, Rami Komrokji⁷, Jason Gotlib⁸, Jean Jacques Kiladjian⁹, Francisco Cervantes¹⁰, Timothy Devos¹¹, Francesca Palandri¹², Valerio De Stefano¹³, Marco Ruggeri¹⁴, Richard T Silver¹⁵, Giulia Benevolo¹⁶, Francesco Albano¹⁷, Chiara Cavalloni⁴, Daniela Barraco¹, Michele Merli¹, Daniela Pietra⁴, Rosario Casalone¹⁸, Tiziano Barbui¹⁹, Giada Rotunno³, Mario Cazzola⁴, Alessandro Maria Vannucchi³, Francesco Passamonti²⁰

Affiliations

¹ Hematology, Department of Medicine and Surgery, University of Insubria, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy.
² Biophysics Institute, National Research Council of Italy, Milano, Italy.
³ CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Department of Experimental and Clinical Medicine, Azienda ospedaliera-Universitaria Careggi, University of Florence, Italy.
⁴ Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Italy.
⁵ University of Milan, Hematology and BMT Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
⁶ Ospedale Niguarda Cà Granda, Milano, Italy.
⁷ Moffit Cancer Center, Tampa, FL, USA.
⁸ Stanford University, Palo Alto, CA, USA.
⁹ Hôpital Saint-Louis et Université Paris Diderot, France.
¹⁰ Hospital Clínic, IDIBAPS, University of Barcelona, Spain.
¹¹ Department of Hematology, University Hospitals Leuven and Laboratory of Experimental Transplantation, Department of Microbiology and Immunology, KU Leuven, Belgium.
¹² Policlinico S. Orsola-Malpighi, Bologna, Italy.
¹³ Università Cattolica del Sacro Cuore, Roma, Italy.
¹⁴ Ospedale S. Bortolo, Vicenza, Italy.
¹⁵ Weill Cornell Medical College, New York, USA.
¹⁶ Centro Oncologico Ematologico Subalpino (COES), Torino, Italy.
¹⁷ Università di Bari, Italy.
¹⁸ Cytogenetics and Medical Genetics Laboratory, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy.
¹⁹ FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy.
²⁰ Hematology, Department of Medicine and Surgery, University of Insubria, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy [email protected].

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers
Biopsy
Bone Marrow / metabolism
Bone Marrow / pathology
Chromosome Aberrations*
Disease Progression
Female
Humans
Male
Middle Aged
Polycythemia Vera / genetics*
Polycythemia Vera / mortality
Polycythemia Vera / pathology
Primary Myelofibrosis / genetics*
Primary Myelofibrosis / mortality
Primary Myelofibrosis / pathology
Prognosis
Thrombocythemia, Essential / genetics*
Thrombocythemia, Essential / mortality
Thrombocythemia, Essential / pathology

Substances

Biomarkers